Market Research Report
Telemedicine - Global Market Outlook (2020-2028)
|Published by||Stratistics Market Research Consulting||Product code||1004618|
|Published||Content info||150+ Pages
Delivery time: 2-3 business days
|Telemedicine - Global Market Outlook (2020-2028)|
|Published: April 1, 2021||Content info: 150+ Pages||
According to Stratistics MRC, the Global Telemedicine Market is accounted for $35.21 billion in 2020 and is expected to reach $393.13 billion by 2028 growing at a CAGR of 35.2% during the forecast period. Increasing number of corona virus positive cases along with the chronic respiratory diseases, technological innovations, and increasing remote patient monitoring is driving the market growth. However, lack of knowledge and trust in developing countries are hampering the growth of the market.
Telemedicine is the modern technology in which physicians can care the patients remotely to the practice when the provider and the patients are not physically present for each other. The physician and patients can share information in real-time from one computer screen to another one. They can see the capture readings from medical devices at a different locations. The benefit of telemedicine is the patients can see the doctors for diagnosis and treatment without having to wait for an appointment.
Based on the end user, the providers segment is going to have lucrative growth during the forecast period as telemedicine solutions improve healthcare quality and offer convenience for healthcare providers in terms of quick access to patient records, improved decision support, provide clinical alerts, and real-time quality reporting. By geography, Asia Pacific is going to have high growth during the forecast period owing to rapid demand for healthcare assistance, especially in the rural areas. Innovation and development towards telecommunication are likely to enhance further the growth in this region in near future.
Some of the key players profiled in the Telemedicine Market include Boehringer Ingelheim, Sanofi, Zoetis, Affinitech, Romvac Company S.A, Merck & Co., Bayer, Indovax, Hester Biosciences Limited, Eli Lilly and Company, CEVA Logistics and Bimeda Inc.
Delivery Models Covered:
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.